Skip to content
Open access

Computational characterization of Paraphamide B as a potential EGFR-preferential dual EGFR/ALK-binding candidate for non-small cell lung cancer

Oct 2026 · In Silico Pharmacology · Vol 14 · 0 citations · 70 references
Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.